Zydelig FDA Approved Drugs
ZYDELIG [IdelalisibC22H18FN7O]
RX
- 100mg (oral tablet)
150mg (oral tablet)
Gilead Sciences IncJul 23, 2014
- A method of disrupting leukocyte function, including as an inhibitor of pi3kdelta kinase.
- For the treatment of patients with cll, fl, or sll.
- For the treatment of patients with relapsed chronic lymphocytic leukemia.
- For the treatment of patients with relapsed follicular b-cell non-hodgkin lymphoma or [relapsed] small lymphocytic lymphoma.
- In combination with rituximab, for the treatment of patients with relapsed chronic lymphocytic leukemia (cll).
- Inhibition on pi3k kinase.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.